Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
Recruiting · NCT07701161 · Registry updated 2026-07-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Not stated | 2026-07-14 | NCT07701161 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Neurogen Biomarking LLC | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Insight Hospital and Medical Center Dearborn | Dearborn | United States | 1 |
| Insight Institute of Neurology and Neurosurgery | Flint | United States | 1 |
| Insigth Hospital and Medical Center Chicago | Chicago | United States | 1 |
| Memorial Healthcare Hospital | Owosso | United States | 1 |
| Wake Forest Baptist Medical Center | Winston-Salem | United States | 25 |